M3 Inc banner

M3 Inc
OTC:MTHRY

Watchlist Manager
M3 Inc Logo
M3 Inc
OTC:MTHRY
Watchlist
Price: 4.67 USD -5.85% Market Closed
Market Cap: $6.3B

EV/EBITDA

10.1
Current
37%
Cheaper
vs 3-y average of 16.2

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
10.1
=
Enterprise Value
$897.6B
/
EBITDA
¥88.1B

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
10.1
=
Enterprise Value
$897.6B
/
EBITDA
¥88.1B

Valuation Scenarios

M3 Inc is trading below its 3-year average

If EV/EBITDA returns to its 3-Year Average (16.2), the stock would be worth $7.47 (60% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-18%
Maximum Upside
+132%
Average Upside
40%
Scenario EV/EBITDA Value Implied Price Upside/Downside
Current Multiple 10.1 $4.67
0%
3-Year Average 16.2 $7.47
+60%
5-Year Average 23.5 $10.85
+132%
Industry Average 8.3 $3.82
-18%
Country Average 8.7 $4
-14%

Forward EV/EBITDA
Today’s price vs future ebitda

Today's Enterprise Value EBITDA Forward EV/EBITDA
$897.6B
/
Jan 2026
¥88.1B
=
10.1
Current
$897.6B
/
Mar 2026
¥92.6B
=
9.7
Forward
$897.6B
/
Mar 2027
¥100B
=
9
Forward
$897.6B
/
Mar 2028
¥110.8B
=
8.1
Forward

Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.

Peer Comparison

All Multiples
EV/EBITDA
P/E
All Countries
Close
Market Cap EV/EBITDA P/E
JP
M3 Inc
OTC:MTHRY
1T USD 10.1 20.8
US
Cerner Corp
LSE:0R00
31.3B USD 21.9 53.1
US
Veeva Systems Inc
NYSE:VEEV
27.5B USD 21.1 30.2
AU
Pro Medicus Ltd
ASX:PME
14.9B AUD 78.4 63.3
SE
Sectra AB
STO:SECT B
51.1B SEK -131.6 95
US
Waystar Holding Corp
NASDAQ:WAY
5B USD 15.4 43.2
US
Doximity Inc
NYSE:DOCS
4.5B USD 14.8 18.7
CN
Winning Health Technology Group Co Ltd
SZSE:300253
19.2B CNY -118 -60.4
US
Vocera Communications Inc
F:V00
2.4B EUR 267.9 -328
US
Heartflow Inc
NASDAQ:HTFL
2.7B USD 0 0
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
245.4B INR 24.3 36.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
M3 Inc
OTC:MTHRY
Average EV/EBITDA: 56.8
10.1
14%
0.7
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
21.1
28%
0.8
AU
Pro Medicus Ltd
ASX:PME
78.4
28%
2.8
SE
Sectra AB
STO:SECT B
Negative Multiple: -131.6 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
15.4
20%
0.8
US
Doximity Inc
NYSE:DOCS
14.8
21%
0.7
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -118
36%
N/A
US
V
Vocera Communications Inc
F:V00
267.9
N/A N/A
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
24.3
139%
0.2
P/E Multiple
Earnings Growth PEG
JP
M3 Inc
OTC:MTHRY
Average P/E: 45.1
20.8
16%
1.3
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
30.2
25%
1.2
AU
Pro Medicus Ltd
ASX:PME
63.3
29%
2.2
SE
Sectra AB
STO:SECT B
95
14%
6.8
US
W
Waystar Holding Corp
NASDAQ:WAY
43.2
55%
0.8
US
Doximity Inc
NYSE:DOCS
18.7
15%
1.2
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -60.4
69%
N/A
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328 N/A N/A
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
36.8
N/A N/A

Market Distribution

Lower than 100% of companies in Japan
Percentile
0th
Based on 5 051 companies
0th percentile
0.1
Low
0.1 — 6.7
Typical Range
6.7 — 12.2
High
12.2 —
Distribution Statistics
Japan
Min 0.1
30th Percentile 6.7
Median 8.7
70th Percentile 12.2
Max 214 699 781.2

M3 Inc
Glance View

M3 Inc. emerged from Japan in the late 1990s, rapidly morphing from a novel digital venture into a formidable player in the global medical information services arena. The company's genesis was rooted in the transformative vision of leveraging web-based platforms to bridge vast distances between healthcare professionals, providing them with timely, accurate information and resources. As the internet began revolutionizing industries, M3 Inc. seized this opportunity, focusing on creating a seamless digital environment that connected pharmaceutical companies with medical professionals. Their flagship offering, M3.com, became a pivotal platform—essentially serving as a nexus where healthcare giants could introduce their latest products and innovations to an audience of medical practitioners, facilitating informed decision-making and nurturing vital industry relationships. Reaching beyond Japanese shores, M3 Inc. strategically expanded its influence into markets in Europe, the United States, and further afield, deftly tailoring its platforms to meet diverse regulatory standards and cultural nuances. Today, its financial vitality is driven by a multifaceted business model. Primarily, M3 derives revenue from pharmaceutical companies and medical device makers who pay for advertising space and market research insights on its network, valuing the direct engagement with physicians it facilitates. Moreover, the company has smartly diversified its portfolio by incorporating online healthcare services and physician recruitment, offering a comprehensive suite of services that cater to the evolving needs of the medical community. By aligning its growth with the digital evolution of the healthcare industry, M3 Inc. continues to solidify its role as a linchpin in the health information ecosystem.

MTHRY Intrinsic Value
LOCKED
Unlock
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett